Skip to main content

Disorders of the Pentose Phosphate Pathway

  • Chapter
  • 4443 Accesses

Abstract

Three inborn errors in the pentose phosphate pathway (PPP) are known.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   159.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Wamelink MM, Struys EA, Jansen EE et al. (2008) Sedoheptulokinase deficiency due to a 57-kb deletion in cystinosis patients causes urinary accumulation of sedoheptulose: elucidation of the CARKL gene. Hum Mutat 29:532–536

    Article  PubMed  CAS  Google Scholar 

  2. Knaap v d MS, Wevers RA, Struys EA et al. (1999) Leukoencephalopathy associated with a disturbance in the metabolism of polyols. Ann Neurol 46:925–928

    Article  Google Scholar 

  3. Huck JHJ, Verhoeven NM, Struys EA et al. (2004) Ribose-5-phosphate isomerase deficiency: new inborn error in the pentose phosphate pathway associated with a slowly progressive leukoencephalopathy. Am J Hum Genet 74:745–751

    Article  PubMed  CAS  Google Scholar 

  4. Verhoeven NM, Huck JH, Roos B et al. (2001) Transaldolase deficiency: liver cirrhosis associated with a new inborn error in the pentose phosphate pathway. Am J Hum Genet 68:1086–1092

    Article  PubMed  CAS  Google Scholar 

  5. Verhoeven NM, Wallot M, Huck JHJ et al. (2005) A newborn with severe liver failure, cardiomyopathy and transaldolase deficiency. J Inherit Metab Dis 28:169–179

    Article  PubMed  CAS  Google Scholar 

  6. Valayannopoulos V, Verhoeven N, Mention K et al. (2006) Transaldolase deficiency: a new cause of hydrops fetalis and neonatal multi-organ disease. J Pediatr 149:713–717

    Article  PubMed  Google Scholar 

  7. Wamelink MM, Struys EA, Salomons GS et al. (2008) Transaldolase deficiency in a two year-old boy with cirrhosis. Mol Genet Metab 29:532–536

    CAS  Google Scholar 

  8. Wamelink MMC, Struys EA, Jakobs C (2008) The biochemistry, metabolism and inherited defect of the pentose phosphate pathway: a review. J Inherit Metab Dis 31:703–717

    Article  PubMed  CAS  Google Scholar 

  9. Tylki-Szymańska A, Stradomska TJ, Wamelink MM et al. (2009) Transaldolase deficiency in two new patients with a relative mild phenotype. Mol Genet Metab 97:15–17

    Article  PubMed  Google Scholar 

  10. Fung CW, Siu S, Mac C et al. (2007) A rare cause of hepatosplenomegaly: transaldolase deficiency. J Inherit Metab Dis 30 [Suppl1] 62

    Google Scholar 

  11. Engelke UFH, Zijlstra FSM, Mochel F et al. (2010) Mitochondrial involvement and erythronic acid as a novel biomarker in transaldolase deficiency. Biochim Biophys Acta 1802:1028–1035

    PubMed  CAS  Google Scholar 

  12. Wamelink MM, Smith DE, Jakobs C et al. (2005) Analysis of polyols in urine by liquid chromatography-tandem mass spectrometry: a useful tool for recognition of inborn errors affecting polyol metabolism. J Inherit Metab Dis 28:951–963

    Article  PubMed  CAS  Google Scholar 

  13. Wamelink MM, Smith DEC, Janssen EEW et al. (2007) Detection of transaldolase deficiency by quantitation of novel seven-carbon chain carbohydrate biomarkers in urine. J Inherit Metab Dis 30:735–742

    Article  PubMed  CAS  Google Scholar 

  14. Huck JH, Struys EA, Verhoeven NM et al. (2003) Profiling of pentose phosphate pathway intermediates in blood spots by tandem mass spectrometry: application to transaldolase deficiency. Clin Chem 49:1375–1380

    Article  PubMed  CAS  Google Scholar 

  15. Wamelink MM, Struys EA, Gonzales M et al. (2008) Retrospective detection of transaldolase deficiency in amniotic fluid. Prenat Diagn 28:460–462

    Article  PubMed  CAS  Google Scholar 

  16. Hanczko R, Fernandez DR, Doherty E et al. (2009) Prevention of hepatocarcinogenesis and increased susceptibility to acetaminophen-induced liver failure in transaldolase-deficient mice by N-acetylcysteine. J Clin Invest 119:1546–1557

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Wamelink, M.M.C., Valayannopoulos, V., Jakobs, C. (2012). Disorders of the Pentose Phosphate Pathway. In: Saudubray, JM., van den Berghe, G., Walter, J.H. (eds) Inborn Metabolic Diseases. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-15720-2_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-15720-2_8

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-15719-6

  • Online ISBN: 978-3-642-15720-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics